Echo Therapeutics (ECTE) Closes 3.2M Offering at 95c/Share
Get Alerts ECTE Hot Sheet
Join SI Premium – FREE
Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the closing of a previously announced underwritten public offering of 3,200,000 shares of its common stock and the fully exercised over-allotment option to purchase 480,000 additional shares, offered at a price of $0.95 per share. The gross proceeds to Echo from this offering were approximately $3.5 million, before deducting the underwriting discount and other offering expenses payable by Echo.
Aegis Capital Corp. acted as the sole book-running manager for the offering.
Feltl and Company acted as co-manager for the offering.
Aegis Capital Corp. acted as the sole book-running manager for the offering.
Feltl and Company acted as co-manager for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Munich Re (MUV2:GR) (MURGY) to Reduce, 'dividend yield remains relatively low'
- Morgan Stanley Downgrades Sanbio Co Ltd. (4592:JP) (SNBIF) to Equalweight
- Terna SpA (TRN:IM) (TERRF) PT Raised to EUR9.10 at HSBC, 'see a continuation of the long-term compounding trend'
Create E-mail Alert Related Categories
Credit Ratings, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!